Saturn V Capital Management LP
Q3 2025 13F Holdings
- Locationaustin, TX
- Num holdings
17
- Value ($000)
$455,971
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001964437
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ABIVAX SA | SPONSORED ADS | 00370M103 | $68.02 M | 15 % | 801,224 | ||
AMLX AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | $62.58 M | 14 % | 4,604,878 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $39.62 M | 9 % | 300,610 | ||
DYN DYNE THERAPEUTICS INC | COM | 26818M108 | $33.83 M | 7 % | 2,674,469 | ||
COGT COGENT BIOSCIENCES INC | COM | 19240Q201 | $29.08 M | 6 % | 2,025,041 | ||
PCVX VAXCYTE INC | COM | 92243G108 | $28.40 M | 6 % | 788,441 | ||
CELC CELCUITY INC | COM | 15102K100 | $23.41 M | 5 % | 473,828 | ||
CGON CG ONCOLOGY INC | COM | 156944100 | $23.36 M | 5 % | 579,895 | ||
IRON DISC MEDICINE INC | COM | 254604101 | $22.53 M | 5 % | 340,897 | ||
PHARVARIS N V | COM | N69605108 | $22.11 M | 5 % | 886,332 |
Rows Per Page
10
- 10
- 50
- 100